MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjopen-2018-022056

Медицинская библиотека · BMJ open · 2018

Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial.

Mone Fionnuala, Mulcahy Cecilia, McParland Peter, Breathnach Fionnuala, Downey Paul, McCormack Dorothy, Culliton Marie, Stanton Alice, Cody Fiona, Morrison John J, Daly Sean, Higgins John, Cotter Amanda, Hunter Alyson, Tully Elizabeth C, Dicker Patrick, Alfirevic Zarko, Malone Fergal D, McAuliffe Fionnuala M

Сравнительное исследованиеСтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Evaluate the feasibility and acceptability of routine aspirin in low-risk women, compared with screening-test indicated aspirin for the prevention of pre-eclampsia and fetal growth restriction.

DESIGN

Multicentre open-label feasibility randomised controlled trial.

SETTING

Two tertiary maternity hospitals in Dublin, Ireland.

PARTICIPANTS

546 low-risk nulliparous women completed the study.

INTERVENTIONS: Women underwent computerised randomisation to: Group 1-routine aspirin 75 mg from 11 until 36 weeks; Group 2-no aspirin and; Group 3-aspirin based on the Fetal Medicine Foundation screening test. PRIMARY AND SECONDARY OUTCOME MEASURES: (1) Proportion agreeing to participate; (2) compliance with protocol; (3) proportion where first trimester uterine artery Doppler was obtainable and; (4) time taken to issue a screening result. Secondary outcomes included rates of pre-eclampsia and small-for-gestational-age fetuses.

RESULTS

546 were included in the routine aspirin (n=179), no aspirin (n=183) and screen and treat (n=184) groups. 546 of 1054 were approached (51.8%) and enrolled. Average aspirin adherence was 90%. The uterine artery Doppler was obtained in 98.4% (181/184) and the average time to obtain a screening result was 7.6 (0-26) days. Of those taking aspirin, vaginal spotting was greater; n=29 (15.1%), non-aspirin n=28 (7.9%), OR 2.1 (95% CI 1.2 to 3.6). Postpartum haemorrhage >500 mL was also greater; aspirin n=26 (13.5%), no aspirin n=20 (5.6%), OR 2.6 (95% CI 1.4 to 4.8).

CONCLUSION

Low-risk nulliparous women are open to taking aspirin in pregnancy and had high levels of adherence. Aspirin use was associated with greater rates of vaginal bleeding. An appropriately powered randomised controlled trial is now required to address the efficacy and safety of universal low-dose aspirin in low-risk pregnancy compared with a screening approach.

TRIAL REGISTRATION NUMBER: ISRCTN (15191778); Post-results.

Для цитирования: Mone Fionnuala, Mulcahy Cecilia, McParland Peter, Breathnach Fionnuala, Downey Paul, McCormack Dorothy, Culliton Marie, Stanton Alice, Cody Fiona, Morrison John J, Daly Sean, Higgins John, Cotter Amanda, Hunter Alyson, Tully Elizabeth C, Dicker Patrick, Alfirevic Zarko, Malone Fergal D, McAuliffe Fionnuala M. Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial.. BMJ open. 2018. DOI: 10.1136/bmjopen-2018-022056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.